The Effects of Chiropractic in a Population With High Central Adiposity

NCT ID: NCT06208163

Last Updated: 2025-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-04

Study Completion Date

2025-09-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Since 1980, the global prevalence of obesity, commonly defined as a body mass index (BMI) of 30 or higher, has doubled. Importantly, high levels of central adiposity (i.e., abdominal fat) is associated with numerous PNI-related sequelae, including increased levels of psychological distress, cognitive deficits, ANS dysfunction, and immune marker abnormalities. To our knowledge, rigorous investigation of chiropractic's impact on psychoneuroimmunological (PNI)-related outcomes in people with high central adiposity is lacking. Based on limited evidence to date, it is plausible that clinically important PNI-related dysfunctions (e.g., heightened stress levels, executive function impairments, dysautonomia, immune dysregulation) common in this population could be ameliorated via chiropractic care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Up to twenty (20) obese individuals (18-65 yrs of age) will be recruited. For our trial, obesity will be indexed as a BMI ≥30 and an elevated waist circumference (i.e., \>35 inches for women, \>40 inches for men).

Subjects will be asked to do the following…

* Restrict certain behaviors prior to their lab visits which include 1) 3 hours prior abstain from caffeine, brushing your teeth, alcohol-based mouthwash, nicotine, food, \& drinking large amounts of liquid very quickly (e.g., chugging a 16 oz bottle of water; sipping water is ok) and 2) 24 hours prior abstain from strenuous exercise, alcohol, \& over the counter drugs (e.g., antihistamines, Tylenol, etc.)
* Have their height, weight, and waist circumference measured.
* Drool into a tube for subsequent testing of immune markers (i.e., salivary IgA)
* Have electrodes placed on/around their chest \& back to measure respiration, ECG, and impedance cardiography (ICG)
* Perform a postural challenge whereby they lay supine (8 min), stand quickly (3 min), and return quickly to the supine position (3 min).
* Have their cognitive function assessed while walking on a treadmill (dual task).
* Answer questions about their mental, physical, and emotional health.
* Receive 6-weeks of chiropractic adjustments from community-based clinicians.

Assessments will take place at baseline, after 2 weeks of chiropractic, and after 6 weeks of chiropractic.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominal Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chiropractic care

6 weeks of chiropractic care

Group Type EXPERIMENTAL

Chiropractic

Intervention Type PROCEDURE

Chiropractic spinal adjustments

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chiropractic

Chiropractic spinal adjustments

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-65 years of age
* Body mass index (BMI) at least 30
* Waist circumference at least 35 inches if female or 40 inches if male

Exclusion Criteria

* Had chiropractic care within the past 30 days
* Prescribed short-acting benzodiazepines which include midazolam \& triazolam
* If taking prescription medications, other than short-acting benzodiazepines, not on a stable dose for a minimum of 6 weeks with plans to change medications or doses during the study
* Not able to walk unassisted on a treadmill
* Known disorder resulting in syncope/fainting during postural changes (e.g., POTS, orthostatic hypotension)
* Pacemaker or known heart condition that influences the electrical or mechanical function of the heart (e.g., severe heart valve disease)
* Diagnosed with externalizing (e.g., substance use, antisocial disorder) or thought (e.g., schizophrenia, paranoid personality, bipolar) disorder that is uncontrolled or untreated
* Diagnosed with rheumatoid arthritis, osteoporosis, or cervical spine instability
* Hearing impairment (cognitive task uses auditory stimuli)
* Currently pregnant
* Current litigation related to a physical, health-related injury
* Whiplash injury in the past 3 months
* Oral injury, inflammation, or disease that causes the mouth or gums to bleed easily
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Georgia

OTHER

Sponsor Role collaborator

Life University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tyson Perez, DC, PhD

Role: PRINCIPAL_INVESTIGATOR

Life University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. Sid E. Williams Center for Chiropractic Research

Marietta, Georgia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

I-0027

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Chiropractic T Cell Study
NCT05412602 COMPLETED NA
Chiropractic Force Versus Touch
NCT05249530 COMPLETED NA
Ciropractic Care and Pregnant Women
NCT04919278 COMPLETED NA
Chiropractic Neuroscience Care in Sports Concussion
NCT07175753 ENROLLING_BY_INVITATION
Cervicogenic Headache Dose-Response
NCT01530321 COMPLETED PHASE1/PHASE2